期刊文献+

晚期糖基化终产物诱导单核细胞产生细胞因子的细胞内信号传导机制 被引量:9

Advanced glycation end products-induced inflammatory reaction in human monocytes:cellular receptor pathway & intracellular signaling
下载PDF
导出
摘要 目的 探讨晚期糖基化终产物 (AGE)诱导单核细胞产生白细胞介素 1β(IL 1β)和肿瘤坏死因子 浕(TNF 浕)的细胞内信号传导机制。方法 采用密度梯度离心法分离健康成人外周血单核细胞 ,经AGE修饰的人血清白蛋白 (AGE HSA)刺激后 ,用ELISA法检测培养上清中IL 1β、TNF 浕水平 ,用化学发光法测定活性氧的生成 ;免疫细胞化学染色及凝胶迁移电泳 (EMSA)法观察核因子 κB(NF κB/p6 5 )的激活。分别用抗AGE受体 (RAGE)抗体、NADPH氧化酶特异性抑制剂apocynin和p38通路抑制剂SB 2 0 35 80预处理单核细胞 ,观察对AGE HSA诱导细胞因子和活性氧产生的影响。结果 AGE HSA与单核细胞在体外共同培养后 ,细胞内NF κB激活 ,培养上清中IL 1β、TNF 浕水平明显增高 ,活性氧生成增加 ;用抗RAGE抗血清或apocynin预处理细胞可阻断AGE HSA诱导的活性氧生成 (P <0 0 1) ,抑制NF κB的活化并使培养上清IL 1β、TNF 浕显著降低 (P <0 0 1)。用SB 2 0 35 80预处理细胞也可抑制AGE HSA诱导的NF κB激活及IL 1β、TNF 浕的产生 ,但对活性氧的产生无明显影响 (P >0 0 5 )。结论 AGE通过RAGE介导的途径刺激单核细胞生成IL 1β、TNF 浕和活性氧 ,NADPH氧化酶途径可能是RAGE细胞内信号途径的上游 。 Objective To investigate the cellular receptor pathway and the intracellular signaling of advanced glycation end products(AGE)-induced inflammatory reaction in monocytes. Methods Human peripheral monocytes were isolated from healthy volunteers. Cells were incubated with AGE modified by the addition of human serum albumin (AGE-HSA) either with pretreatment or no pretreatment of anti-AGE receptor (RAGE) IgG, NADPH oxidase inhibitor (apocynin)or a specific inhibitor of p38(SB 203580). The levels of interleukin-1β(IL-1β)and tumor necrosis factor-α(TNF-α) in the supernatants were assayed with enzyme-linked immunoadsorbent assay (ELISA). Reactive oxygen species (ROS) production was determined by MCLA chemiluminescence. Nuclear factor-κB translocation was assayed by immunochemical staining with anti-NF-κB/p65 and electrophoretic mobility shift assay(EMSA). Results AGE-HSA was found to induce activation of NF-κB, increase levels of IL-1β and TNF-α in the supernatants, and enhance production of ROS by monocytes. Pre-treatment of cells with anti-RAGE IgG or apocynin inhibited AGE-HSA to induce NF-κB translocation and IL-1β or TNF-α production. AGE stimulated ROS production could also be blocked by pre-treatment of cultured cells with anti-RAGE IgG or apocynin. Pre-treatment of cultured cells with SB 203580 inhibited both NF-κB activation and cytokines production, but showed no significant effect the cells to produce ROS. Conclusion AGE-HSA could induce IL-1β and TNF-α release as well as ROS production in human monocytes via a pathway mediated by RAGE. Activation of NADPH oxidase may be the upstream of the intracellular pathway. AGE-induced cytokines production was p38 pathway-dependent.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2004年第11期947-950,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学重点项目基金(编号 30 330 30 0 ) 广东省团队项目(编号 1 0 71 7)资助课题
关键词 糖基化终产物 高级 活性氧组分 NADPH氧化酶 NF-κB 白细胞介素-1 肿瘤坏死因子 advanced glycosylation end products reactive oxygen species (ROS) NADPH oxidase NF-kappa B interleukin-1 tumor necrosis factor
  • 相关文献

参考文献14

  • 1[1]Bucala R, Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kindney Dis,1995,26(6):875
  • 2[2]Hou FF, Owen WF Jr. Beta 2-microglobulin amyloidosis: role of monocytes/macrophages. Curr Opin Nephrol Hypertens,2002, 11(4):417
  • 3[3]Miyata T, Sugiyama S, Saito A et al. Reaction carbony1 compounds related uremic toxicity "carbony1 stress". Kidney Int, 2001, 78:S25
  • 4朱平,唐磊,赵善超,卢晓,候凡凡,富宁.抗人晚期糖基化终产物受体胞外段不同表位单克隆抗体的制备[J].第一军医大学学报,2004,24(2):129-132. 被引量:6
  • 5[5]Hou FF ,Boyce J, Chertow GM et al. A minoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol,1998,9(2):277
  • 6[6]Hou FF, Miyata T, Boyce J et al. Beta (2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int,2001, 59(3):990
  • 7任昊,侯凡凡,张训.肝素对血液透析病人单核细胞表面晚期糖基化终产物受体的影响[J].中华内科杂志,2002,41(1):43-46. 被引量:11
  • 8[8]Veronique WS, Mitko S, Miriam F et al. Advanced oxidation products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol,1998,161(5):2524
  • 9[9]Miyata T, Kurokawa K, Strihou C et al. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int,2000,58(Suppl 76):S120
  • 10[10]Hou FF, Jiang JP, Guo JQ et al. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol,2002,13(5):1296

二级参考文献19

  • 1[1]Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues[J]. Am J Pathol, 1993, 143(6): 1699-712.
  • 2[2]Hori O, Yan SD, Ogawa S, et al. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus [J]. Nephrol Dial Transplant, 1996,11 (Suppl 5):13-6.
  • 3[3]Miyata T, Hori O, Zhang J, e t al Thereceptor for advaneed glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2 microglobulin with human mononucleεr phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis [J ]. J Clin Invest, 1996, 98(5): 1088-94.
  • 4[4]Sasaki N, Toki S, Chowei H, et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer'sdisease [J]. Brain Res, 2001, 888 (2):256-62.
  • 5[5]Chappey O, Dosquet C, Wautier MP, et al. Advanced glycation end products, oxidant stress and vascular lesions[ J ]. Eur J Clin Invest,1997, 27(2): 97-108.
  • 6[6]Hsieh HL, Schafer BW, Sasaki N, et al. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays [ J ].Biochem Biophys Res Commun, 2003, 307(2): 375-81.
  • 7[7]Ishihara K, Tsutsumi K, Kawane S, et al. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site[J]. FEBS Lett, 2003, 550(1-3): 107-13.
  • 8[8]Hou FF, Chertow GM, Kay J, et al. Interaction between β 2m and AGE in the development of dialysis-related amyloidnsis[J]. Kidney Int, 1997, 51(5): 1514-9.
  • 9[9]Wautier JL, Zoukourian C, Chappey O, et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy, soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rat[J]. J Clin Invest, 1996, 97(1): 238-43.
  • 10Sugiyama S, Miyata T, Horie K, et al. Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant, 1996,11 Suppl 5: 91-94.

共引文献15

同被引文献125

引证文献9

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部